Full results & analysis
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRP for Medial Retinaculum Tear
NCT00743873Phase 3
Key facts
- Status
- Completed
- Start
- Jan 2008
- Primary completion
- Feb 2009
- Countries
- 1
- Sponsor
- Meir Medical Center
- Modality
- Cell Therapies
- Drugs
- PRGF-Endoret
- Conditions
- Patellar dislocation
01
Overview
Phase 3, randomised, double-blind trial in Patellar dislocation comparing PRGF with Placebo (2 arms). Primary endpoints: Reduction in healing time at 1 year and Reduction in recurrent dislocation of the patella at 1 year. Started Jan 2008; status: completed.
02
Design
2 arms- Study design
- RandomizedDouble-blind
PRGF
Plasma Rich in Growth Factors injection
Placebo
Saline injection
03
Endpoints
Primary
Reduction in healing time
Reduction in recurrent dislocation of the patella
Beyond the preview
Go deeper on NCT00743873.
Full results, competitive context and analysis are in the Gosset platform.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00743873.